Healthcare
Live Price
Offline$16.99
+0.00% today
Window Change
-36.44%
Window
Jan 1, 2026 → Jun 11, 2026
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 115 bars · Jan 1, 2026 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
ResMed Inc. (RSMDF) is a Healthcare stock with a market cap of $30.51B and listed on OTC. The stock last traded around $16.99 and down 36.4% across the available one-year price window (Jan 1, 2026 → Jun 11, 2026). Baseline metrics include revenue growth of +9.8%, EPS growth of +37.6%, a dividend yield of 1.1%. What stands out right now is revenue +9.8%, EPS +37.6%, free cash flow +29.2% with operating margin 34.3% and ROIC 19.6%. The dividend is present but secondary, with a yield around 1.1%. Valuation sits in the middle of the pack at P/E 20.2 and price/sales 5.5. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines RSMDF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RSMDF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
RSMDF Max Drawdown
-58.05%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for RSMDF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
Latest Revenue
—
Latest Net Income
—
Free Cash Flow
—
Revenue Growth
+9.8%
EPS Growth
+37.6%
Gross Margin
61.7%
Net Margin
27.4%
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.